Ventura Elvira

Dutt Mahasweta, Tabuena Philomela, Ventura Elvira, Rostami Abdolmohamad, Shindler Kenneth S

Studying experimental optic neuritis, early corticosteroid treatment before inflammation onset prevented retinal ganglion cell loss, but later treatment was less effective. This suggests chronic immunomodulation may be crucial.

Shindler Kenneth S, Ventura Elvira, Rex Tonia S, Elliott Peter, Rostami Abdolmohamad

SIRT1 activators protected retinal ganglion cells from damage in experimental optic neuritis, suggesting a novel neuroprotective strategy to prevent vision loss in patients, potentially alongside anti-inflammatory treatments.